» Articles » PMID: 35283578

Hypervitaminosis D and Acute Interstitial Nephritis: Tale of Injections

Overview
Specialty Nephrology
Date 2022 Mar 14
PMID 35283578
Authors
Affiliations
Soon will be listed here.
Abstract

A 33-year-old man came with nausea, vomiting and abdominal pain due to hypercalcaemia and renal dysfunction following two doses of intramuscular vitamin D injections. Levels of vitamin D were repeatedly above 300 ng/ml over a period of 10 months. Whole-body PET CT scan revealed a thin-walled collection in the right gluteal region. The patient refused a surgical intervention for the same. After 7 months of follow-up, the abscess ruptured spontaneously and was then surgically debrided. At this point, a history of pentazocine addiction was uncovered. One month later, vitamin D levels began to fall along with improvement in serum calcium and creatinine. This case unravels a diagnostic odyssey which ended with a simple surgical debridement. We aim to highlight that vitamin D supplementation in 'megadoses' in the presence of active infection can have an exaggerated response and may take months to resolve.

References
1.
Cipriani C, Romagnoli E, Pepe J, Russo S, Carlucci L, Piemonte S . Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. J Clin Endocrinol Metab. 2013; 98(7):2709-15. DOI: 10.1210/jc.2013-1586. View

2.
Selby P, Davies M, Marks J, Mawer E . Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol (Oxf). 1995; 43(5):531-6. DOI: 10.1111/j.1365-2265.1995.tb02916.x. View

3.
Multani S, Sarathi V, Shivane V, Bandgar T, Menon P, Shah N . Study of bone mineral density in resident doctors working at a teaching hospital. J Postgrad Med. 2010; 56(2):65-70. DOI: 10.4103/0022-3859.65272. View

4.
Diamond T, Ho K, Rohl P, Meerkin M . Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust. 2005; 183(1):10-2. DOI: 10.5694/j.1326-5377.2005.tb06879.x. View

5.
Dusso A, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S . gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab. 1997; 82(7):2222-32. DOI: 10.1210/jcem.82.7.4074. View